Navidea Biopharmaceuticals Inc.

AMEX: NAVBHealthcare / Biotechnology / USA
0.900000.00Vol 299 6271Y Perf -81.88%
Sep 20th, 2019 16:00
BID0.8600 ASK0.9000
Open0.9300 Previous Close0.9100
Pre-Market0.92 After-Trading0.88
 0.02 2.22%  -0.02 -2.22%
Target Price
2.00 
Analyst Rating
Strong Buy 1.00
Potencial %
122.22 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
+     30.46
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Buy
Price Range Ratio 52wk %
5.93 
Earnings Date
6th Nov 2019

Today's Price Range

0.88000.9600

52wk Range

0.49007.40

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Buy
Performance
1 Week
28.57%
1 Month
73.08%
3 Months
30.43%
6 Months
-67.86%
1 Year
-81.88%
3 Years
-8.16%
5 Years
-32.33%
10 Years
-33.82%

Name / TickerPriceChg.Chg.%
NAVB0.90000.00000.00
AAPL217.73-3.2300-1.46
GOOG1 229.93-8.7800-0.71
MSFT139.44-1.6300-1.16
XOM72.08-0.2500-0.35
WFC48.63-0.2800-0.57
JNJ131.651.54001.18
FB189.93-0.2100-0.11
GE9.37-0.0500-0.53
JPM118.90-0.4800-0.40
Earnings HistoryEstimateReportedSurprise %
Q04 2017--0.03-
Q04 2016--0.02-
Q03 2016-0.00-
Q02 2016--0.04-
Q01 2016--0.02-
Q04 2015--0.02-
Q03 2015--0.05-
Q02 2015--0.03-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date6th Nov 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume299 627
Shares Outstanding (in ths.)10 059
Trades Count206
Dollar Volume174 321
Avg. Volume175 161
Avg. Weekly Volume226 728
Avg. Monthly Volume109 332
Avg. Quarterly Volume320 774
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
0 (0.00 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
RatingStrong Buy
1.00
Strong Buy
1.00
-

Navidea Biopharmaceuticals Inc.

Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products, are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

CEO: Jed A. Latkin

Teplephone: +1 614 793-7500

Address: 4995 Bradenton Avenue, Dublin 43017-3552, OH, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

47%53%

Bearish Bullish

52%48%

Bearish Bullish

58%42%

News